# Hospital Wing Opening Sparks Antimicrobial Resistance in Wastewater Microbial Community Within the First Twelve Months

**Authors:** Laura Lohbrunner, Claudia Baessler, Elena Becker, Christina Döhla, Nina Droll, Ralf M. Hagen, Niklas Klein, Nico T. Mutters, Alexander Reyhe, Ruth Weppler, Manuel Döhla

PMC · DOI: 10.3390/microorganisms14020285 · Microorganisms · 2026-01-26

## TL;DR

A new hospital wing caused a rapid rise in antibiotic-resistant microbes in wastewater within the first year of operation.

## Contribution

This study provides quantitative evidence that hospital activity rapidly drives antimicrobial resistance in wastewater microbial communities.

## Key findings

- Bacterial concentrations in wastewater increased significantly after patient treatment began.
- Pseudomonas spp. became the dominant genus in wastewater samples.
- Resistance to key antibiotic classes emerged within twelve months of hospital operation.

## Abstract

Antimicrobial resistance (AMR) in hospital wastewater is a recognized public health concern, yet the dynamics of its emergence remain poorly understood. This study aimed to characterize the quantitative and qualitative changes in the microbial community of a newly built internal medicine intensive care hospital wing following the start of patient treatment. Wastewater samples were collected regularly from eight relevant sites, including seven patient-associated locations within the intensive care ward and the central sanitary sewer where all effluent converged. Culture-based analyses targeted the “ESCAPE-SO” bacterial and fungal groups (“Enterococci”, “Staphylococci”, “Candida”, “Acinetobacter”, “Pseudomonas”, “Enterobacteriaceae”, “Stenotrophomonas”, “Others”). Comparisons were made between a 12-month pre-operation period (only flushing every 72 h to prevent contamination of the drinking water system) and the first 12 months of patient treatment. The results showed a significant increase in mean bacterial concentrations from 53 [0–349] CFU/mL before patient treatment to 8423 [3054–79,490] CFU/mL during patient treatment (p = 0.0224) with a particular focus on Pseudomonas spp. as the dominant genus. Resistance against all four main antibiotic classes of the WHO AWaRe essential “watch” list (carbapenems, third-generation cephalosporins, broad-spectrum penicillin and ciprofloxacin) emerged within the first twelve months and depended on the amount of prescribed antibiotics and the number of patients treated. These findings indicate that hospital activity drives rapid development of antimicrobial resistance in wastewater microbial communities, highlighting the critical role of clinical antibiotic use in shaping environmental resistomes. This study provides quantitative evidence that resistance can emerge within months of hospital operation, emphasizing the need for early monitoring and targeted interventions to mitigate the spread of AMR from hospital effluents into broader environmental systems.

## Linked entities

- **Species:** Pseudomonas sp. #P (taxon 299395)

## Full-text entities

- **Diseases:** AMR (MESH:D060467), DDDs (MESH:D020773), Stenotrophomonas (MESH:C531821), injury to (MESH:D014947), DDD (MESH:C562924), infection (MESH:D007239), CIP (MESH:C565467), deaths (MESH:D003643), P. aeruginosa (MESH:D011552), fungal (MESH:D009181), Infectious diseases (MESH:D003141)
- **Chemicals:** agar (MESH:D000362), Ciprofloxacin (MESH:D002939), carbon (MESH:D002244), Clarithromycin (MESH:D017291), Azithromycin (MESH:D017963), NaCl (MESH:D012965), Piperacillin (MESH:D010878), Tazobactam (MESH:D000078142), MPM (MESH:C083299), water (MESH:D014867), CAZ (MESH:D002442), Vancomycin (MESH:D014640), Carbapenem (MESH:D015780), Meropenem (MESH:D000077731), Cefepime (MESH:D000077723), cephalosporins (MESH:D002511), Ceftriaxone (MESH:D002443), Piperacillin with Tazobactam (MESH:D000077725), Fluoroquinolones (MESH:D024841), DDD (-), Cefotaxime (MESH:D002439), PTZ (MESH:D010433), Cefuroxime (MESH:D002444), penicillin (MESH:D010406), beta-lactam (MESH:D047090), alcohol (MESH:D000438), Imipenem (MESH:D015378), Cefixime (MESH:D020682)
- **Species:** Stenotrophomonas (genus) [taxon 40323], Pseudomonas aeruginosa (species) [taxon 287], Klebsiella pneumoniae (species) [taxon 573], Acinetobacter (genus) [taxon 469], Enterobacterales (order) [taxon 91347], Fungi (kingdom) [taxon 4751], Enterococcus faecalis (species) [taxon 1351], Staphylococcus aureus (species) [taxon 1280], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Candida [taxon 1535326], Homo sapiens (human, species) [taxon 9606], Enterococcus faecium (species) [taxon 1352], Enterobacteriaceae (enterobacteria, family) [taxon 543], Pseudomonas (RNA similarity group I, genus) [taxon 286], Acinetobacter baumannii (species) [taxon 470]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12943030/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12943030/full.md

## References

46 references — full list in the complete paper: https://tomesphere.com/paper/PMC12943030/full.md

---
Source: https://tomesphere.com/paper/PMC12943030